P8IP
BLUE

Pier 88 Investment Partners’s bluebird bio BLUE Stock Holding History

Pier 88 Investment Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-940
Closed -$657K – 123
2020
Q3 		$657K Buy
940
+161
+21% +$126K 0.2% 86
2020
Q2 		$616K Buy
+779
New +$587K 0.18% 91

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Pier 88 Investment Partners's BLUE Position: Q4 2020 in Review

Pier 88 Investment Partners sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 940 shares — an estimated $657K sold.

Pier 88 Investment Partners first reported a position in BLUE in Q2 2020 and held it in 2 quarters. The position peaked at $657K in Q3 2020. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Pier 88 Investment Partners reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Pier 88 Investment Partners sold 940 bluebird bio shares in Q4 2020, an estimated $657K.
  • Pier 88 Investment Partners first reported a position in bluebird bio in Q2 2020 and held it in 2 quarters.
  • Pier 88 Investment Partners's bluebird bio position peaked at $657K in Q3 2020.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Pier 88 Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.